- Home
- AKA vs ORMP Comparison
AKA vs ORMP Comparison
Compare AKA & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AKA | ORMP |
|---|---|---|
| Founded | 2018 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 121.7M | 134.1M |
| IPO Year | 2021 | 2010 |
Fundamental Metrics
Financial Performance| Metric | AKA | ORMP |
|---|---|---|
| Price | $9.82 | $3.25 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $24.33 | N/A |
| AVG Volume (30 Days) | 1.4K | ★ 164.3K |
| Earning Date | 06-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.61% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.26 |
| Revenue | ★ $600,208,000.00 | $1,340,000.00 |
| Revenue This Year | $5.83 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $2.61 |
| Revenue Growth | ★ 4.44 | N/A |
| 52 Week Low | $7.00 | $1.82 |
| 52 Week High | $16.90 | $3.76 |
Technical Indicators
Market Signals| Indicator | AKA | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 38.64 | 47.00 |
| Support Level | $9.31 | $3.22 |
| Resistance Level | $12.08 | $3.76 |
| Average True Range (ATR) | 0.27 | 0.21 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 17.30 | 22.22 |
Price Performance
Historical ComparisonAbout AKA a.k.a. Brands Holding Corp.
a.k.a. Brands Holding Corp is an online fashion retailer focused on acquiring and accelerating the growth of next-generation, digitally native fashion brands targeting Gen Z and Millennial customers. The brands of the company are two women's brands, Princess Polly and Petal & Pup, and two streetwear brands, Culture Kings and mnml. The company derives maximum revenue from Australia/New Zealand.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.